Deep Isolation Nuclear Appoints Dr. Arati Prabhakar to Board
| Field | Detail |
|---|---|
| Company | Deep Isolation Nuclear, Inc. |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $97,500 b, $3.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-appointment, executive-compensation, financial-statements
TL;DR
Deep Isolation Nuclear adds Dr. Arati Prabhakar to its board, filing financial updates.
AI Summary
Deep Isolation Nuclear, Inc. announced on October 17, 2025, the appointment of Dr. Arati Prabhakar as a new director. The company also reported on compensatory arrangements for certain officers and provided financial statements and exhibits. This filing follows a name change from Aspen-1 Acquisition Inc. on March 17, 2022.
Why It Matters
The appointment of a prominent figure like Dr. Arati Prabhakar could signal strategic advancements or increased credibility for Deep Isolation Nuclear in the energy and transportation sector.
Risk Assessment
Risk Level: medium — The filing involves executive appointments and financial disclosures, which can impact investor confidence and company direction.
Key Players & Entities
- Deep Isolation Nuclear, Inc. (company) — Registrant
- Dr. Arati Prabhakar (person) — Newly appointed director
- Aspen-1 Acquisition Inc. (company) — Former company name
- October 17, 2025 (date) — Date of earliest event reported
- March 17, 2022 (date) — Date of name change
FAQ
Who is Dr. Arati Prabhakar and what is her background relevant to Deep Isolation Nuclear?
The filing does not provide specific details on Dr. Prabhakar's background or relevance, but she is listed as a newly appointed director.
What specific compensatory arrangements for officers are detailed in this filing?
The filing indicates that compensatory arrangements of certain officers are being reported, but the specific details are not provided in the provided text.
What are the key financial statements and exhibits included with this 8-K filing?
The filing states that Financial Statements and Exhibits are included, but the content of these documents is not detailed in the provided text.
What was the reason for the name change from Aspen-1 Acquisition Inc. to Deep Isolation Nuclear, Inc.?
The filing states the date of the name change (March 17, 2022) but does not provide the reason for the change.
What is the primary business of Deep Isolation Nuclear, Inc.?
The filing lists the Standard Industrial Classification as REFUSE SYSTEMS [4953] and mentions '01 Energy & Transportation', suggesting a focus in these areas.
Filing Stats: 1,110 words · 4 min read · ~4 pages · Grade level 10.8 · Accepted 2025-10-21 16:52:59
Key Financial Figures
- $97,500 b — k units ("RSUs") with a market value of $97,500 based on a price per share of $3.00 and 1
- $3.00 — f $97,500 based on a price per share of $3.00 and 10,833 stock options with an exerci
Filing Documents
- ea0261764-8k_deep.htm (8-K) — 37KB
- ea026176401ex99-1_deep.htm (EX-99.1) — 17KB
- image_001.jpg (GRAPHIC) — 5KB
- ex99-1_001.jpg (GRAPHIC) — 8KB
- ex99-1_002.jpg (GRAPHIC) — 61KB
- 0001213900-25-100860.txt ( ) — 332KB
- cik0001918080-20251017.xsd (EX-101.SCH) — 3KB
- cik0001918080-20251017_lab.xml (EX-101.LAB) — 33KB
- cik0001918080-20251017_pre.xml (EX-101.PRE) — 22KB
- ea0261764-8k_deep_htm.xml (XML) — 3KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 17, 2025, the Board of Directors (the "Board") of Deep Isolation Nuclear, Inc. (the "Company") unanimously appointed Ms. Rene Hornbaker as a Class A director, effective immediately. Ms. Hornbaker, age 73, has more than four decades of corporate leadership experience. She previously served as CFO at each of Stream Energy, Shared Technologies and Flowserve Corporation ("Flowserve"). She also served as Vice President of Business Development and Information Technologies at Flowserve. Ms. Hornbaker is also a Certified Public Accountant and began her career with the audit practice of Deloitte. She also currently serves on the boards of directors of Eastman Chemical Company, Freeman Company and Berry Corporation, where she serves as Board Chair. Additionally, Ms. Hornbaker also holds a Directorship Certification from the National Association of Corporate Directors ("NACD"), currently serves as chair emeritus of the NACD North Texas Chapter and was previously named by NACD as its 2023 Private Company Director of the Year and as an outstanding CFO. Ms. Hornbaker will serve as a Class A Director of the Company, with a term expiring at the next annual meeting of the Company's stockholders. Ms. Hornbaker has been appointed to serve on the Nominating and Governance Committee, Compensation Committee and Audit Committee of the Board. The Board has affirmatively determined that Ms. Hornbaker is "independent" within the meaning of Nasdaq's and the Securities and Exchange Commission's (the "SEC") corporate governance rules. Ms. Hornbaker was not selected as a director pursuant to any arrangements or understandings with the Company or with any other person. There are no related party transactions between Ms. Hornbaker or any member of her immediate family and the Company that would require disclosure under Item
01
Item 7.01 Regulation FD Disclosure On October 21, 2025, the Company issued a press release announcing Ms. Hornbaker's appointment to the Board. A copy of the press release is furnished as Exhibit 99.1 and incorporated herein by reference. The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly incorporated by reference in such filing. Item 9.01 Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release, dated October 21, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DEEP ISOLATION NUCLEAR, INC. Date: October 21, 2025 By: /s/ Rodney Baltzer Rodney Baltzer President and Chief Executive Officer 2